Publicaciones (47) Publicaciones en las que ha participado algún/a investigador/a

2023

  1. 3D Printing Technologies in Personalized Medicine, Nanomedicines, and Biopharmaceuticals

    Pharmaceutics, Vol. 15, Núm. 2

  2. A novel osmoprotective liposomal formulation from synthetic phospholipids to reduce in vitro hyperosmolar stress in dry eye treatments

    Journal of Liposome Research, Vol. 33, Núm. 2, pp. 117-128

  3. An overview of in vitro 3D models of the blood-brain barrier as a tool to predict the in vivo permeability of nanomedicines

    Advanced Drug Delivery Reviews, Vol. 196

  4. Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems

    Pharmaceutics, Vol. 15, Núm. 1

  5. Análisis farmacocinético poblacional de digoxina en pacientes ancianos

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  6. Application of Accelerated Predictive Stability Studies in Extemporaneously Compounded Formulations of Chlorhexidine to Assess the Shelf Life

    Molecules, Vol. 28, Núm. 23

  7. Can amphotericin B and itraconazole be co-delivered orally? Tailoring oral fixed-dose combination coated granules for systemic mycoses

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 183, pp. 74-91

  8. Can covid-19 be classified among the culprits of neurodegeneration and accelerators of neurodegenerative diseases? Has a new delinquent for neurodegenerative diseases being found?

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  9. Cannabidiol (CBD) use in breast cancer chemotherapy

    Medicinal Usage of Cannabis and Cannabinoids (Elsevier), pp. 373-383

  10. Capacitación de alumnos de pregrado en la generación de contenidos divulgativos de Farmacia y Tecnología Farmacéutica para su difusión en entornos virtuales

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  11. Caracterización en vitro de formulaciones de Meloxicam: difracción de rayos X y microscopio electrónico de barrido

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  12. Celecoxib-loaded PLGA nanoparticles for the treatment ofrheumatoid arthritis: in ovo assessment of theirantiangiogenic effect

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  13. Co-Delivery of a High Dose of Amphotericin B and Itraconazole by Means of a Dry Powder Inhaler Formulation for the Treatment of Severe Fungal Pulmonary Infections

    Pharmaceutics, Vol. 15, Núm. 11

  14. Continuous Manufacturing of Cocrystals Using 3D-Printed Microfluidic Chips Coupled with Spray Coating

    Pharmaceuticals, Vol. 16, Núm. 8

  15. Desarrollo de microemulsiones de administración tópicaocular como plataforma para el tratamiento o prevención dela enfermedad de ojo seco

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  16. Desarrollo de una formulación antiglaucomatosa tópica a partir de una lágrima artificial

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  17. Design, synthesis and biological evaluation of antiparasitic dinitroaniline-ether phospholipid hybrids

    Bioorganic Chemistry, Vol. 138

  18. Development of Chitosan/Sodium Carboxymethylcellulose Complexes to Improve the Simvastatin Release Rate: Polymer/Polymer and Drug/Polymer Interactions’ Effects on Kinetic Models

    Polymers, Vol. 15, Núm. 20

  19. Diseño de formulaciones para terapia combinada frente alglioblastoma

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  20. Effect of Clindamycin on Intestinal Microbiome and Miltefosine Pharmacology in Hamsters Infected with Leishmania infantum

    Antibiotics, Vol. 12, Núm. 2